The Enterprise Value as of December 2025 (TTM) for NeoCore Technology Co., Ltd. (4131.TWO) is 1.57B

According to NeoCore Technology Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.57B. This represents a change of 28.60% compared to the average of 1.22B of the last 4 quarters.

NeoCore Technology Co., Ltd. (4131.TWO) Historical Enterprise Value (quarterly & annually)

How has 4131.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of NeoCore Technology Co., Ltd. over the last ten years is 518.90M. The current 1.57B Enterprise Value has changed 30.25% with respect to the historical average. Over the past ten years (40 quarters), 4131.TWO's Enterprise Value was at its highest in in the March 2025 quarter at 1.40B. The Enterprise Value was at its lowest in in the December 2022 quarter at 461.01M.

NeoCore Technology Co., Ltd. (4131.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NeoCore Technology Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NeoCore Technology Co., Ltd. (4131.TWO) Average Enterprise Value

How has 4131.TWO Enterprise Value performed in the past?

The current Enterprise Value of NeoCore Technology Co., Ltd. (4131.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

NeoCore Technology Co., Ltd. (4131.TWO) Enterprise Value vs. Peers

How is 4131.TWO’s Enterprise Value compared to its peers?

NeoCore Technology Co., Ltd.’s Enterprise Value is greater than MegaPro Biomedical Co., Ltd (935.80M), greater than LabTurbo Biotech Corporation (749.86M), greater than Taiwan Advance Bio-Pharmaceutical Inc. (1.22B), greater than GeneReach Biotechnology Corp. (1.26B), greater than Lukas Biomedical Inc. (1.42B), greater than Bio Preventive Medicine Corp. (941.58M), greater than Great Novel Therapeutics Biotech & Medicals (1.29B), greater than Neith Corporation (1.09B), greater than Level Biotechnology Inc. (846.65M), greater than LAUNXP Biomedical Co., Ltd (1.00B),

Build a custom stock screener for NeoCore Technology Co., Ltd. (4131.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeoCore Technology Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeoCore Technology Co., Ltd. (4131.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeoCore Technology Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.